Clinical Trial Update: Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on a stem cell therapy using Alpha/Beta T and CD19+ depleted peripheral stem cells for primary immunodeficiency diseases; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Dysregulation Syndrome
• Immunodeficiency Disease

Drugs mentioned

• Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Immunodeficiencies, Immune Dysregulation Syndromes | Phase 2 | Status: ACTIVE_NOT_RECRUITING